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1. Introduction 
Seizures are the most frequent clinical manifestation associated with neurocysticercosis 
(NCC) [1]. But, not all patients with NCC and seizures will develop epilepsy [2)]. Nearly 
85% of patients with a single NCC in transitional or degenerative phase have a good seizure 
outcome following resolution of the lesion, and antiepileptic drugs (AEDs) withdrawal [3)]. 
Patients with residual calcifications and those with both recurrent seizures and multiple 
cysts before treatment with albendazole have the highest rate of relapse after complete 
disappearance of the cysts and withdrawal of AEDs [4]. Cerebral calcifications are a 
common finding in persons with seizures or epilepsy in endemic populations [5], and 
perilesional edema is associated with episodic seizure activity in patients with calcified NCC 
[6]. However, a high rate of negative correlations between the electroclinical localization and 
the topography of intracranial calcification has been reported [7], and an irritative zone in 
the temporal lobe is more relevant in determining the severity and frequency of seizures, 
than the number and location of calcifications [8].  
Drug-resistant epilepsy (DRE) is now defined as “failure of two adequate trials, 
appropriately chosen and tolerated AEDs schedules (whether as monotherapy or in 
combination) to achieve sustained seizure freedom” [9].  NCC is an uncommon cause of 
DRE, even in endemic regions [10]. Perilesional gliosis (best visualized on magnetization 
transfer spin-echo magnetic resonance imaging), may cause seizures that could be difficult 
to control with antiepileptic drugs (AEDs) in patients with a solitary cysticercal cyst in the 
brain [11, 12].  
Epilepsy surgery is highly effective in selected patients with DRE, has durable benefits, and 
improves quality of life [13]. The standard presurgical evaluation should encompass careful 
history and physical examination, interictal electroencephalography (EEG) including sleep, 
prolonged video EEG monitoring, magnetic resonance imaging (MRI) with specific 
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sequences, and neuropsychological assessment. In some cases, invasive monitoring with 
intracranially-placed electrodes is needed for the purpose of seizure localization. Epilepsy 
surgery as a treatment of DRE due to NCC has been uncommonly reported.  
2. Epilepsy surgery and NCC 
Rassi Neto et al. [14], in 1998, reported three cases of patients with DRE associated to 
calcified neurocysticercotic lesions in the temporal lobe. Two of them had MRI imaging, and 
one of the studies showed perilesional edema. In all cases, the epileptiform focus was 
demonstrated by EEG. The patients were submitted to removal of the lesion with use of 
perioperative electrocorticogram, also rendering possible removal of the irritative 
perilesional focus. In all the cases, the histologic examination showed NCC. However, the 
authors did not report complete histological description. Out-patient follow-up was 
approximately 30 months. Two patients were seizure-free and one patient presented an 
improvement of 95% in seizure frequency.  
Chung et al. [15], in 1998, reported a 47-year-old man with intractable temporal lobe 
epilepsy. Computed tomography (CT) and MRI imaging showed a calcification in the region 
of the left medial temporal lobe, and atrophy of the hippocampal head portion. Interictal 
EEG and prolonged video-EEG monitoring were compatible with left temporal lobe 
epilepsy. The patient underwent standard left temporal lobectomy. Histologic examination 
revealed degenerated cysticercus and scolex, with the surrounded hippocampus showing a 
fascia dentada with neuronal loss and gliosis. He was seizure-free for two years after the 
first postoperative day. 
Ooi et al. [16], in 2011, presented a 23-year-old male with recurrent focal seizures despite 
continued treatment with AED. CT and MRI imaging showed a calcified lesion with 
surrounding edema in the right frontal lobe that waxed and waned over time. After 
extensive presurgical evaluation, including mapping of the seizure focus to the right frontal 
lobe, the lesion was excised. The histological description was available. The capsule, around 
a degenerated cysticercus, contained marked mononuclear infiltrates that extended to 
adjacent brain, which showed marked astrocytosis, microgliosis, and inflammatory 
perivascular infiltrates. The patient was seizure-free for a period of 2 years while on AEDs 
until he presented again with seizures associated with perilesional edema around the one 
cyst in the left frontal lobe that had evolved into a calcified granuloma.  
Based on these cases published in the literature, it appears important to presurgically 
identify the presence of perilesional gliosis (around the cysticercotic lesion), as this appeared 
to be an important predictor of seizure freedom following surgery. This would indicate the 
important role of gliosis in the generation of seizures, which are particularly difficult to treat 
in this group of patients. The technique of magnetization transfer spin-echo magnetic 
resonance imaging is useful for this purpose, as well as the use of electrocorticography 
when possible, which would allow delineating the epileptogenic tissue. 
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3. Epilepsy surgery in NCC and coexistence of other lesions 
The association of NCC with hippocampal sclerosis (HS) has been reported in developing 
countries [17, 18]. In a cross-sectional study of 512 patients with DRE, 54.8% of them had HS, 
and 37% of them presented with HS plus NCC [19]. The mechanism of this association is not 
clarified. First, NCC might work as an initial precipitating injury leading to HS [20]. Second, 
the occurrence of NCC lesions in association with HS, or vice versa, may be merely 
coincidental [21]. Finally, both diseases might share common predisposing factors [10]. 
Leite et al. [21], in Brazil, determined the clinical and pathologic findings of 30 patients with 
HS and compared them with 32 patients with HS and calcified cysticercotic lesions (CCL) 
from an epilepsy surgery program. Preoperative data localized the focus to the anterior 
temporal region and patients were referred for a standardized en-bloc resection including 2 
to 3 cm of the hippocampus. In three patients, a CCL ipsilateral to the atrophic hippocampus 
was located within the margins of resection and removed. The mean follow-up was 29.7 
months. The percentage of patients with very good seizure control was similar in both 
groups. 81.2% patients in the HS + CCL group and 76.6% in the HS group had seizure-free 
outcome (p = 0.90]. No differences were found between the 2 groups in regards to age at 
seizure onset, hippocampal cell densities, or fascia dentata neo-Timm’s staining patterns. 
Accordingly, their findings indicate that there is no need for removal of CCL in order to 
achieve good postsurgical seizure control in this set of patients.  
Chandra et al. [22], in India, presented a series of 28 DRE cases resulting from post-
infectious etiologies requiring surgery. All patients underwent a complete epilepsy 
presurgical evaluation. The criteria used to define infection-related DRE included absence of 
other potential etiologies preceding the infection as a cause of epilepsy. This was 
determined by reviewing the clinical history and MRI/CT scans performed at the time of 
onset of initial infection (the authors did not report if this initial MRI scan was with a special 
epilepsy protocol). The mean duration of epilepsy prior to surgery was 8.2 ± 2.1 years. 
Patients were followed after surgery for an average of 14.2 months. The pathologies 
included NCC in six cases. Four of the five cases with NCC in the temporal lobe, had HS. 
Histology of one of these cases showed evidence of early HS (not detected earlier on MRI, 
but with significant spike activity in electrocorticography). Free-seizure outcome was seen 
in all six cases. 
In our center, one patient with DRE NCC-related epilepsy was assessed for possible 
epilepsy surgery. He was a 39 year-old man who had a previous history of a single, non-
febrile, generalized tonic–clonic seizure at age of 5. At age of 13, he began to experience 
recurrent seizures consisting of fear, followed by loss of awareness associated with unusual 
movement of the hands. He then would scream, run and have forceful eye deviation to the 
left. Postictal confusion and aggressiveness were reported. The episodes were lasting from 
two to five minutes and they would occur one to two times a month. Once a year, those 
events would be followed by a secondarily generalized tonic-clonic seizure. He had an 
unclear history of central nervous system infection at the age of two years and some 
developmental delay. He had been treated with three different AEDs before he was referred 
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to our epilepsy program. He was a Mexican Mennonite, who immigrated to  Canada at the 
age of 6 years, with frequent travels to his country of origin. The CT scan and the MRI study 
revealed right HS as well as 3 extratemporal calcified cysticerci (Figure 1). Initial presurgical 
evaluation indicated possible frontal epilepsy (Figure 2), but subsequent placement of 
intracranial electrodes identified that seizures arose from the right mesial temporal lobe 
(Figure 3). He underwent a right temporal lobectomy and has been seizure free for over 2 
years. 
 
 
 
 
Figure 1. Preoperative imaging studies in one patient with drug resistant epilepsy. (A, B and C) Serial 
CT scan of the patient showing 3 extratemporal calcified cysticerci. (D) MRI fluid-attenuated inversion 
recovery (FLAIR) reveals a focal high signal intensity lesion in the right mesial temporal region and 
minimal atrophy of the hippocampus support hippocampal sclerosis. 
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Figure 2. Initial presurgical evaluation in one patient with drug resistant epilepsy with right 
hippocampal sclerosis and three extratemporal calcified cysticerci. Video electroencephalography 
monitoring was obscured by movement and muscle artifact (arrow), but the semiology of the seizures 
captured on video, were concerning for a possible extratemporal lobe focus, despite the initial symptom 
of fear. 
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Figure 3. Presurgical evaluation in one patient with drug resistant epilepsy with right hippocampal 
sclerosis and three extratemporal calcified cysticerci. (A and B) Localization of the intracranial 
electrodes. (C) Invasive recordings show an ictal onset from the mesial right temporal lobe. 
4. Conclusions 
Epilepsy surgery in NCC is rare but effective. Patient with DRE and NCC should be referred 
for consideration of epilepsy surgery.  The presurgical evaluation is essential and extensive 
investigations at experienced centers may also be required. NCC itself is not necessarily the 
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epileptogenic lesion in this set of patients. The association of NCC and HS is rather frequent, 
further studies are necessary to clarify the mechanisms of this association.  
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